Magnitude Matters
TBMG-15695
02/01/2013
- Content
Topping the agenda of medtech executives for 2013 is repeal of the medical device excise tax, which went into effect on January 1. Enacted as part of the healthcare reform legislation of 2010, the new law requires manufacturers, producers, and importers to pay a tax of 2.3% on the sales price of most medical devices sold in the United States. The Internal Revenue Service issued final regulations and interim guidelines for the tax in December 2012.
- Citation
- "Magnitude Matters," Mobility Engineering, February 1, 2013.